In an ID8 ovarian cancer tumor model it was demonstrated that PD-L1 blockade can restore antitumor immunity, and synergize with whole tumor antigen vaccine (GVAX) to produce tumor rejection. The gene discussed is CD274; the disease is neoplasm.